Eton Pharmaceuticals (ETON) EBT (2018 - 2025)

Eton Pharmaceuticals has disclosed EBT across 8 years of filings, most recently posting $1.4 million for Q4 2025.

• EBT for Q4 2025 came in at $1.4 million, up 376.71% year-over-year; the trailing twelve-month figure through Dec 2025 was -$4.6 million (down 19.7% YoY), and the FY2025 annual result was -$4.6 million, down 19.7% from the prior year.
• EBT came in at $1.4 million for Q4 2025 at Eton Pharmaceuticals, up from -$2.0 million in the prior quarter.
• In the past five years, EBT ranged from a high of $5.1 million in Q1 2021 to a low of -$6.1 million in Q3 2021.
• The 5-year median for EBT is -$1.5 million (2022), against an average of -$1.0 million.
• Across the five-year window, EBT jumped 392.62% in 2023 and tumbled 490.22% in 2025, its largest moves.
• Eton Pharmaceuticals' EBT stood at $1.0 million in 2021, then declined by 12.22% to $912000.0 in 2022, then slumped by 320.29% to -$2.0 million in 2023, then jumped by 74.56% to -$511000.0 in 2024, then jumped by 376.71% to $1.4 million in 2025.
• The last three EBT figures came in at $1.4 million (Q4 2025), -$2.0 million (Q3 2025), and -$2.5 million (Q2 2025), per Business Quant data.